Your session is about to expire
← Back to Search
Virus Therapy
Asthmatic for Asthma
Phase 2
Waitlist Available
Led By Larry Borish, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in symptom score from day 0 to day 4 after inoculation with the rhinovirus
Awards & highlights
Study Summary
This study is evaluating whether a nasal inoculation of a virus can cause asthma in people with asthma.
Eligible Conditions
- Asthma
- Allergy or Hay Fever
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in symptom score from day 0 to day 4 after inoculation with the rhinovirus
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in symptom score from day 0 to day 4 after inoculation with the rhinovirus
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Symptom Scores Induced by the Rhinovirus Using Jackson Criteria Including Nasal Congestion, Drainage, Cough, Wheezing
Trial Design
3Treatment groups
Active Control
Group I: AsthmaticActive Control1 Intervention
Asthmatic subjects will be infected with Rhinovirus (GMP RV16 human (H)RV-16)
Group II: Allergic rhinitisActive Control1 Intervention
Allergic rhinitis subjects will be infected with Rhinovirus (GMP RV16 HRV-16)
Group III: Healthy controlActive Control1 Intervention
Healthy controls will be infected with Rhinovirus (GMP RV16 HRV-16)
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,993 Total Patients Enrolled
10 Trials studying Asthma
753 Patients Enrolled for Asthma
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,541 Total Patients Enrolled
58 Trials studying Asthma
8,269 Patients Enrolled for Asthma
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,481,094 Total Patients Enrolled
58 Trials studying Asthma
11,497 Patients Enrolled for Asthma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger